Drug
Curcumin C3 complex®
Curcumin C3 complex® is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_2
4
100%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 24 (100.0%)
Trials by Status
completed250%
active_not_recruiting125%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_2
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
NCT03598309
not_yet_recruitingphase_2
Topical Curcumin for HPV Related Cervical Disease
NCT04266275
completedphase_2
Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients
NCT01042938
completedphase_2
Curcumin in Patients With Mild to Moderate Alzheimer's Disease
NCT00099710
Clinical Trials (4)
Showing 4 of 4 trials
NCT03598309Phase 2
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
NCT04266275Phase 2
Topical Curcumin for HPV Related Cervical Disease
NCT01042938Phase 2
Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients
NCT00099710Phase 2
Curcumin in Patients With Mild to Moderate Alzheimer's Disease
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4